Investor profile

SeedtoB Capital logo

SeedtoB Capital

VC

USHealthtechAI/ML

See how your deck fits this investor's thesis, stage, and ticket size.

Analyse your fit

Investment thesis

SeedtoB Capital invests in early-stage healthcare technology companies that leverage artificial intelligence to deliver clinical and community impact. The firm targets U.S.-based startups with at least $500K in annual recurring revenue or a clear path to reach that milestone, focusing on highly scalable business models using differentiated technology, especially AI. As former founders of Jvion, the nation's largest clinical AI company, the partners understand that most clinical applications of AI fail to scale beyond pilot settings despite huge investments. Their unique approach helps entrepreneurs navigate the complex healthcare landscape toward the most efficient path from Seed to Series B and ultimately, company success.

Notable quotes

Tumor boards and care collaboration are within a space needing much innovation. OncoLens is stepping up and leading this charge with a very innovative approach under stellar leadership. We're extremely excited to welcome OncoLens to our portfolio.

Shantanu Nigam · OncoLens Series A Announcement · 2021-01-14

Team

Shantanu Nigam

Managing Partner

HealthtechAI/ML

Ritesh Sharma

Managing Partner

HealthtechAI/ML

Vikrant Vaid

Associate

Healthtech

Maya Menon

Consultant

Healthtech

Eller Kelliher

Venture Advisor

Healthtech

Recent investments

CompanyRoundSizeDate
Marvix AISeed2025-10-01
TERN GroupSeries A$24m2025-09-10
CanidSeries A-II$10m2025-06-03
AngelEye HealthSeries C$9m2025-12-01
Cybersenzunknown2026-01-01
Interactly AIunknown2024-12-01
OncoLensSeries A$7m2021-01-14
Biotiaunknown
Scripta Insightsunknown
Moonlight Therapeuticsunknown

Frequent co-investors

VC firmDeals together
Leo Capital2
BIP Capital1
Martin Ventures1
EQ2 Ventures1
Notion Capital1
RTP Global1

Fit check

Is SeedtoB Capital a match for your startup?

Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.

Analyse your fit